138 related articles for article (PubMed ID: 29807145)
41. Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12.
Lupien M; Jeyakumar M; Hébert E; Hilmi K; Cotnoir-White D; Loch C; Auger A; Dayan G; Pinard GA; Wurtz JM; Moras D; Katzenellenbogen J; Mader S
Mol Endocrinol; 2007 Apr; 21(4):797-816. PubMed ID: 17299137
[TBL] [Abstract][Full Text] [Related]
42. Increased antitumor potential of the raloxifene prodrug, raloxifene diphosphate.
Okamoto Y; Liu X; Suzuki N; Okamoto K; Sekimoto M; Laxmi YR; Shibutani S
Int J Cancer; 2008 May; 122(9):2142-7. PubMed ID: 18183587
[TBL] [Abstract][Full Text] [Related]
43. Growth-stimulatory and transcriptional activation properties of raloxifene in human endometrial Ishikawa cells.
Barsalou A; Dayan G; Anghel SI; Alaoui-Jamali M; Van de Velde P; Mader S
Mol Cell Endocrinol; 2002 Apr; 190(1-2):65-73. PubMed ID: 11997179
[TBL] [Abstract][Full Text] [Related]
44. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
45. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
Cai M; Lee KW; Choi SM; Yang EJ
Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
[TBL] [Abstract][Full Text] [Related]
46. Characterization of a membrane-associated estrogen receptor in a rat hypothalamic cell line (D12).
Deecher DC; Swiggard P; Frail DE; O'Connor LT
Endocrine; 2003 Dec; 22(3):211-23. PubMed ID: 14709794
[TBL] [Abstract][Full Text] [Related]
47. Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders.
Espejo-Porras F; Piscitelli F; Verde R; Ramos JA; Di Marzo V; de Lago E; Fernández-Ruiz J
J Neuroimmune Pharmacol; 2015 Jun; 10(2):233-44. PubMed ID: 25819934
[TBL] [Abstract][Full Text] [Related]
48. Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient Rat.
Posa A; Szabó R; Kupai K; Berkó AM; Veszelka M; Szűcs G; Börzsei D; Gyöngyösi M; Pávó I; Deim Z; Szilvássy Z; Juhász B; Varga C
Oxid Med Cell Longev; 2017; 2017():2176749. PubMed ID: 28770019
[TBL] [Abstract][Full Text] [Related]
49. ITH33/IQM9.21 provides neuroprotection in a novel ALS model based on TDP-43 and Na
Mouhid Al-Achbili L; Moreno-Ortega AJ; Matías-Guiu J; Cano-Abad MF; Ruiz-Nuño A
Neurosci Lett; 2016 Oct; 633():28-32. PubMed ID: 27619542
[TBL] [Abstract][Full Text] [Related]
50. Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts.
Katzburg S; Hendel D; Waisman A; Posner GH; Kaye AM; Somjen D
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):213-9. PubMed ID: 15084353
[TBL] [Abstract][Full Text] [Related]
51. Selective estrogen receptor modulation in pancreatic β-cells and the prevention of type 2 diabetes.
Tiano J; Mauvais-Jarvis F
Islets; 2012; 4(2):173-6. PubMed ID: 22543247
[TBL] [Abstract][Full Text] [Related]
52. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
[TBL] [Abstract][Full Text] [Related]
53. The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line.
Somjen D; Katzburg S; Sharon O; Grafi-Cohen M; Knoll E; Stern N
J Cell Biochem; 2011 Feb; 112(2):625-32. PubMed ID: 21268084
[TBL] [Abstract][Full Text] [Related]
54. Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes.
Li R; Xu W; Chen Y; Qiu W; Shu Y; Wu A; Dai Y; Bao J; Lu Z; Hu X
PLoS One; 2014; 9(4):e94320. PubMed ID: 24722370
[TBL] [Abstract][Full Text] [Related]
55. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.
Ding X; Ma M; Teng J; Teng RK; Zhou S; Yin J; Fonkem E; Huang JH; Wu E; Wang X
Oncotarget; 2015 Sep; 6(27):24178-91. PubMed ID: 26172304
[TBL] [Abstract][Full Text] [Related]
56. Nonmuscle myosin IIB regulates Parkin-mediated mitophagy associated with amyotrophic lateral sclerosis-linked TDP-43.
Jun MH; Jang JW; Jeon P; Lee SK; Lee SH; Choi HE; Lee YK; Choi H; Park SW; Kim J; Jang DJ; Lee JA
Cell Death Dis; 2020 Nov; 11(11):952. PubMed ID: 33154354
[TBL] [Abstract][Full Text] [Related]
57. Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats.
Esposito E; Iacono A; Raso GM; Pacilio M; Coppola A; Di Carlo R; Meli R
Endocrinology; 2005 Aug; 146(8):3301-8. PubMed ID: 15860553
[TBL] [Abstract][Full Text] [Related]
58. Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.
Yang R; Ma YX; Chen LF; Zhou Y; Yang ZP; Zhu Y; Du XL; Shi JD; Ma HS; Zhang J
Asian J Androl; 2010 Sep; 12(5):735-43. PubMed ID: 20473319
[TBL] [Abstract][Full Text] [Related]
59. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
[TBL] [Abstract][Full Text] [Related]
60. Mechanism of action and preclinical profile of raloxifene, a selective estrogen receptor modulation.
Bryant HU
Rev Endocr Metab Disord; 2001 Jan; 2(1):129-38. PubMed ID: 11704975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
